Xin Wang v. Injective Labs Inc.

CourtDistrict Court, D. Delaware
DecidedFebruary 6, 2026
Docket1:22-cv-00943
StatusUnknown

This text of Xin Wang v. Injective Labs Inc. (Xin Wang v. Injective Labs Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Xin Wang v. Injective Labs Inc., (D. Del. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

XIN WANG, § § Plaintiff, § § v. § Civil Action No. 22-943 § INJECTIVE LABS INC., § § Defendant. § §

MEMORANDUM OPINION AND ORDER This order is directed to two issues that arose prior to the trial in this case: (1) whether to permit the plaintiff, Xin Wang, to introduce the deposition testimony of Zhonghan “Eric” Chen in the plaintiff’s case-in-chief at trial; and (2) whether to permit the plaintiff to call the defendant’s expert, Franck Risler, as a witness in the plaintiff’s case-in-chief. 1. The Use of Mr. Chen’s Deposition in the Plaintiff’s Case-in-Chief. The plaintiff wishes to introduce the deposition of defendant Injective’s Chief Executive Officer, Zhonghan “Eric” Chen, in the plaintiff’s case-in-chief, even though Mr. Chen will be available at trial and plans to testify for the defendant Injective in the defense case. In seeking to introduce Mr. Chen’s deposition testimony in the plaintiff’s case-in-chief, the plaintiff relies on Rule 32(a)(3) of the Federal Rules of Civil Procedure. That Rule provides as follows: “An adverse party may use for any purpose the deposition of a party or anyone who, when deposed, was the party’s officer, director, managing agent, or designee under Rule 30(b)(6) or 31(a)(4).” The plaintiff cites a number of cases holding that Rule 32(a)(3) authorizes the admission of a party’s deposition even when the party is available and will testify separately at trial. See Dkt. No. 254 (citing numerous cases). The defendant objects. It argues that the court should not allow the plaintiff to introduce Mr. Chen’s deposition in the plaintiff’s case-in-chief, even though Mr. Chen will be available at

trial and plans to testify during the defense case. In the defendant’s view, doing so would erode “the core truth-seeking function” of the trial and would be inefficient and confusing to the jury. Dkt. No. 248 at 2–3. The defendant argues that the right to introduce a party’s pretrial deposition under Rule 32(a)(3) is not unlimited, but is subject to the court’s authority under Rule 611(a) of the Federal Rules of Evidence to control trial proceedings. That rule provides as follows: Rule 611. Mode and Order of Examining Witnesses and Presenting Evidence (a) Control by the Court; Purposes. The court should exercise reasonable control over the mode and order of examining witnesses and presenting evidence so as to: (1) make those procedures effective for determining the truth; (2) avoid wasting time; and (3) protect witnesses from harassment or undue embarrassment.

The plaintiff is correct that a number of courts have held that Rule 32(a)(3) allows a party to introduce the deposition of an adverse party regardless of whether the adverse party is available or even plans to testify as a witness at trial. See, e.g., Fenstermacher v. Phila. Nat’l Bank, 493 F.2d 333, 338 (3d Cir. 1974); Creative Consumer Concepts, Inc. v. Kreisler, 563 F.3d 1070, 1079–80 (10th Cir. 2009); Fey v. Walston & Co., 493 F.2d 1036, 1046 (7th Cir. 1974); 8A Charles Alan Wright et al., Federal Practice & Procedure § 2145 at 641–42 (3d ed. 2010) (“The trial court has discretion to exclude parts of the deposition that are unnecessarily repetitious in relation to the testimony of the party on the stand, but it may not refuse to allow the deposition to be used merely because the party is available to testify in person.”) (citing Community Counselling Serv, Inc. v. Reilly, 317 F.2d 239, 243 (4th Cir. 1963) (Haynesworth, J)). Moreover, courts have frequently stated that Rule 32(a)(3) must be “liberally construed” in favor of the admission of deposition testimony from an adverse party. See Merchants Motor Freight v. Downing, 227 F. 2d 247, 249– 50 (8th Cir. 1955) (the Rule is broad and “has been liberally interpreted”); Smith v. City of Chicago, No. 21-cv-1159, 2025 WL 1744919, at *31 (N.D. Ill. June 24, 2025); Keawsri v. Ramen-Ya Inc., No. 17-cv-2406, 2022 WL 2391692 (S.D.N.Y. July 1, 2022); SEC v. Ambassador Advisors, LLC,

No. 5:20-cv-2274, 2022 WL 2188146 (E.D. Pa. Mar. 7, 2022); Estate of Thompson v. Kawasaki Heavy Indus., Ltd., 291 F.R.D. 297, 305–06 (N.D. Iowa 2013); Redd v. N.Y. State Div. of Parole, 923 F. Supp. 2d 393, 408 (E.D.N.Y. 2013). Courts have uniformly held that a trial court may restrict a party’s use of the deposition of an opposing party if the deposition is cumulative or irrelevant. See, e.g., Keawsri, 2022 WL 2391692, at *1; Hopman v. Union Pac. R.R., No. 4:18-cv-74, 2021 WL 2694236, at *14 (E.D. Ark. June 30, 2021); Eastman Chem. Co. v. SGS N. Am., Inc., No. 4:18-cv-74, 2019 WL 10960575, at *4 (E.D. Tenn. Feb. 4, 2019); Stepanovich v. Bradshaw, No. 2:14CV270, 2017 WL 5249535, at *1 (M.D. Fla. Apr. 17, 2017). But it is a significant step farther for a court to prohibit a party from

introducing relevant and non-cumulative evidence in its case because the court believes the evidence, although admissible, should either be used only for impeachment or, if admitted at all, should be admitted only later in the trial, such as in the party’s rebuttal case. The strongest arguments for allowing a district court to prevent a party from introducing a witness’s deposition testimony when that witness (either a party, an officer of the party, or the party’s Rule 30(b)(6) witness) is available and is expected to testify at trial are (1) that there is a strong preference for live testimony at trial, as opposed to deposition testimony, and (2) introducing deposition testimony in lieu of or in addition to live testimony would be inefficient and potentially confusing to the jury. That was the point made by the district court in Gonzalez Prod. Sys. v. Martinrea Int’l Inc., 310 F.R.D. 341, 342–44 (E.D. Mich. 2015), which contains the most thoughtful analysis of the issue among the 15 cases cited by the defendant. But even the court in that case seemed to recognize that the issue was far from clear-cut, as the court noted a split among district courts on the issue and rested its decision heavily on the district court’s “broad discretion in determining the manner in which [the court] conducts trial.” Id. at 344 (quoting United States v.

Henderson, No. 94-5645, 1995 WL 122785, at *11 (6th Cir. Mar. 21, 1995). Numerous district courts have ruled to the contrary, holding that the authorization for the admission of deposition testimony in Rule 32(a)(3) is not subject to restriction through the courts’ exercise of their discretion. The leading case so holding is Estate of Thompson v. Kawasaki Heavy Indus., Ltd., 291 F.R.D. 297 (N.D. Iowa 2013), which contains an in-depth discussion of the issue. The court in that case concluded that “I ha[ve] discretion to exclude parts of the deposition that are unnecessarily repetitious in relation to the testimony of the party on the stand,” but I “may not refuse to allow the deposition to be used merely because the party is available to testify in person.’” 291 F.R.D. at 306 (quoting N. Ins. Co. v. N.Y. v. Albin Mfg., Inc., No. 06-190, 2008 WL 3285852, at

*3–4 (D.R.I. Aug. 8, 2008)); see also, e.g., Wainberg v. Piedmont Univ., No. 2:19-cv-251, 2025 WL 3125975, at *1 (N.D. Ga.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Brazos River Authority v. GE Ionics, Inc.
469 F.3d 416 (Fifth Circuit, 2006)
Creative Consumer Concepts, Inc. v. Kreisler
563 F.3d 1070 (Tenth Circuit, 2009)
United States v. Gregory Tyree Henderson
50 F.3d 11 (Sixth Circuit, 1995)
DG&G v. FlexSol Packaging Corp. of Pompano Beach
576 F.3d 820 (Eighth Circuit, 2009)
Redd v. New York State Division of Parole
923 F. Supp. 2d 393 (E.D. New York, 2013)
Penn National Insurance v. HNI Corp.
245 F.R.D. 190 (M.D. Pennsylvania, 2007)
Doe v. Eli Lilly & Co.
99 F.R.D. 126 (District of Columbia, 1983)
Zimmerman v. Safeway Stores, Inc.
410 F.2d 1041 (D.C. Circuit, 1969)
Pingatore v. Montgomery Ward & Co.
419 F.2d 1138 (Sixth Circuit, 1969)
Kaufman v. Edelstein
539 F.2d 811 (Second Circuit, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
Xin Wang v. Injective Labs Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/xin-wang-v-injective-labs-inc-ded-2026.